ROCKWELL MEDICAL, INC. Selling and Marketing Expense
ROCKWELL MEDICAL, INC. (RMTI) reported Selling and Marketing Expense of $577.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. selling and marketing expense for the quarter ending 2026-06-30 was $577.00K, a 0.87% increase year-over-year.
- ROCKWELL MEDICAL, INC. selling and marketing expense for the quarter ending 2026-03-31 was $567.00K, a 20.25% decline year-over-year.
- ROCKWELL MEDICAL, INC. selling and marketing expense for the quarter ending 2025-12-31 was $540.00K, a 35.94% decline year-over-year.
- ROCKWELL MEDICAL, INC. selling and marketing expense for the quarter ending 2025-09-30 was $531.00K, a 26.86% decline year-over-year.
- ROCKWELL MEDICAL, INC. selling and marketing expense for fiscal 2025 was $2.35M, a 14.37% decline from fiscal 2024.
- ROCKWELL MEDICAL, INC. selling and marketing expense for fiscal 2024 was $2.75M, a 29.36% increase from fiscal 2023.
- ROCKWELL MEDICAL, INC. selling and marketing expense for fiscal 2023 was $2.13M, a 1.48% increase from fiscal 2022.
- ROCKWELL MEDICAL, INC. selling and marketing expense for fiscal 2022 was $2.09M, a 63.47% decline from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $577.00K 10-Q · filed 2026-08-13 | $1.14M 10-Q · filed 2026-08-13 | $1.68M derived: sum of 3 quarters · filed 2026-08-13 | $2.21M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $567.00K 10-Q · filed 2026-05-07 | $1.11M derived: sum of 2 quarters · filed 2026-05-07 | $1.64M derived: sum of 3 quarters · filed 2026-05-07 | $2.21M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | $540.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.07M derived: sum of 2 quarters · filed 2026-03-26 | $1.64M derived: sum of 3 quarters · filed 2026-08-13 | $2.35M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $531.00K 10-Q · filed 2025-11-12 | $1.10M derived: sum of 2 quarters · filed 2026-08-13 | $1.81M 10-Q · filed 2025-11-12 | $2.66M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $572.00K 10-Q · filed 2026-08-13 | $1.28M 10-Q · filed 2026-08-13 | $2.13M derived: sum of 3 quarters · filed 2026-08-13 | $2.85M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $711.00K 10-Q · filed 2026-05-07 | $1.55M derived: sum of 2 quarters · filed 2026-05-07 | $2.28M derived: sum of 3 quarters · filed 2026-05-07 | $2.87M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $843.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $1.57M derived: sum of 2 quarters · filed 2026-03-26 | $2.15M derived: sum of 3 quarters · filed 2026-03-26 | $2.75M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $726.00K 10-Q · filed 2025-11-12 | $1.31M derived: sum of 2 quarters · filed 2025-11-12 | $1.91M 10-Q · filed 2025-11-12 | $2.45M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $586.00K 10-Q · filed 2025-08-14 | $1.18M 10-Q · filed 2025-08-14 | $1.72M derived: sum of 3 quarters · filed 2025-08-14 | $2.28M derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | $594.00K 10-Q · filed 2025-05-12 | $1.14M derived: sum of 2 quarters · filed 2025-05-12 | $1.69M derived: sum of 3 quarters · filed 2025-05-12 | $2.22M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $541.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $1.10M derived: sum of 2 quarters · filed 2025-03-20 | $1.63M derived: sum of 3 quarters · filed 2025-03-20 | $2.13M 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $556.00K 10-Q · filed 2024-11-12 | $1.09M derived: sum of 2 quarters · filed 2024-11-12 | $1.58M 10-Q · filed 2024-11-12 | $1.94M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $530.00K 10-Q · filed 2024-08-08 | $1.03M 10-Q · filed 2024-08-08 | $1.38M derived: sum of 3 quarters · filed 2024-08-08 | $2.14M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $498.00K 10-Q · filed 2024-05-14 | $849.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.61M derived: sum of 3 quarters · filed 2024-05-14 | $2.14M derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.11M derived: sum of 2 quarters · filed 2024-03-21 | $1.64M derived: sum of 3 quarters · filed 2024-03-21 | $2.09M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $762.00K 10-Q · filed 2023-11-14 | $1.29M derived: sum of 2 quarters · filed 2023-11-14 | $1.74M 10-Q · filed 2023-11-14 | $2.62M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $526.00K 10-Q · filed 2023-08-14 | $981.00K 10-Q · filed 2023-08-14 | $1.85M derived: sum of 3 quarters · filed 2023-08-14 | $3.40M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $455.00K 10-Q · filed 2023-05-15 | $1.33M derived: sum of 2 quarters · filed 2023-05-15 | $2.87M derived: sum of 3 quarters · filed 2023-05-15 | $4.34M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $873.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $2.41M derived: sum of 2 quarters · filed 2023-03-30 | $3.88M derived: sum of 3 quarters · filed 2023-03-30 | $5.73M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $1.54M 10-Q · filed 2022-11-14 | $3.01M derived: sum of 2 quarters · filed 2022-11-14 | $4.86M 10-Q · filed 2022-11-14 | $6.99M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.47M 10-Q · filed 2022-08-15 | $3.32M 10-Q · filed 2022-08-15 | $5.45M derived: sum of 3 quarters · filed 2022-08-15 | $7.12M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $1.85M 10-Q · filed 2022-05-16 | $3.98M derived: sum of 2 quarters · filed 2022-05-16 | $5.65M derived: sum of 3 quarters · filed 2022-05-16 | $7.65M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $3.80M derived: sum of 2 quarters · filed 2022-04-08 | $5.80M derived: sum of 3 quarters · filed 2022-04-08 | $7.87M 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | $1.67M 10-Q · filed 2021-11-15 | $3.67M derived: sum of 2 quarters · filed 2021-11-15 | $5.74M 10-Q · filed 2021-11-15 | $7.64M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $2.00M 10-Q · filed 2021-08-16 | $2.00M 10-Q · filed 2020-08-10 | $4.07M 10-Q · filed 2021-08-16 | $4.07M 10-Q · filed 2020-08-10 | $5.97M derived: sum of 3 quarters · filed 2021-08-16 | $7.80M derived: sum of 4 quarters · filed 2021-08-16 | ||
| 2020-03-31 | $2.07M 10-Q · filed 2021-05-17 | $2.07M 10-Q · filed 2020-05-11 | $3.97M derived: sum of 2 quarters · filed 2021-05-17 | $5.80M derived: sum of 3 quarters · filed 2021-05-17 | $8.02M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $3.73M derived: sum of 2 quarters · filed 2021-03-31 | $5.95M derived: sum of 3 quarters · filed 2021-03-31 | $9.05M 10-K · filed 2021-03-31 | $9.05M 10-K · filed 2020-03-17 | |||
| 2019-09-30 | $1.83M 10-Q · filed 2020-11-09 | $1.83M 10-Q · filed 2019-11-12 | $4.05M derived: sum of 2 quarters · filed 2020-11-09 | $7.15M 10-Q · filed 2020-11-09 | $7.15M 10-Q · filed 2019-11-12 | $7.44M derived: sum of 4 quarters · filed 2020-11-09 | ||
| 2019-06-30 | $2.22M 10-Q · filed 2020-08-10 | $5.32M 10-Q · filed 2020-08-10 | $5.61M derived: sum of 3 quarters · filed 2020-08-10 | $5.73M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $3.10M 10-Q · filed 2020-05-11 | $3.39M derived: sum of 2 quarters · filed 2020-05-11 | $3.51M derived: sum of 3 quarters · filed 2020-05-11 | $3.68M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $288.17K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $410.04K derived: sum of 2 quarters · filed 2020-03-17 | $574.42K derived: sum of 3 quarters · filed 2020-03-17 | $1.00M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | $121.87K 10-Q · filed 2019-11-12 | $286.25K derived: sum of 2 quarters · filed 2019-11-12 | $716.41K 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | $164.37K 10-Q · filed 2019-08-09 | $379.46K 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | $215.08K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |